Publication | Closed Access
Intravenous ω‐3 Fatty Acids Plus Gemcitabine
22
Citations
23
References
2015
Year
Intravenous ω-3FAs in combination with gemcitabine shows evidence of improved activity and benefit to QOL in patients with advanced pancreas cancer and is worthy of investigation in a randomized phase III trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1